Novavax gains on DSMB analysis for RSV vaccine

Novavax Inc. (NASDAQ:NVAX) jumped $0.79 (59%) to $2.12 on Wednesday after presenting results from an "informational analysis" of

Read the full 181 word article

User Sign In